nodes	percent_of_prediction	percent_of_DWPC	metapath
Clorazepate—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.155	0.282	CbGbCtD
Clorazepate—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.105	0.19	CbGbCtD
Clorazepate—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0997	0.182	CbGbCtD
Clorazepate—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0889	0.162	CbGbCtD
Clorazepate—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0522	0.095	CbGbCtD
Clorazepate—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0493	0.0897	CbGbCtD
Clorazepate—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00883	0.0276	CcSEcCtD
Clorazepate—Tension—Roflumilast—chronic obstructive pulmonary disease	0.0082	0.0256	CcSEcCtD
Clorazepate—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00811	0.0254	CcSEcCtD
Clorazepate—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00783	0.0245	CcSEcCtD
Clorazepate—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00658	0.0206	CcSEcCtD
Clorazepate—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00634	0.0198	CcSEcCtD
Clorazepate—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00625	0.0195	CcSEcCtD
Clorazepate—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00617	0.0193	CcSEcCtD
Clorazepate—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00588	0.0184	CcSEcCtD
Clorazepate—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00565	0.0455	CbGpPWpGaD
Clorazepate—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00562	0.0176	CcSEcCtD
Clorazepate—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00547	0.0171	CcSEcCtD
Clorazepate—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00541	0.0169	CcSEcCtD
Clorazepate—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00531	0.0166	CcSEcCtD
Clorazepate—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00522	0.0163	CcSEcCtD
Clorazepate—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00512	0.016	CcSEcCtD
Clorazepate—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00499	0.0402	CbGpPWpGaD
Clorazepate—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00495	0.0155	CcSEcCtD
Clorazepate—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00489	0.0153	CcSEcCtD
Clorazepate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00451	0.0141	CcSEcCtD
Clorazepate—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00437	0.0137	CcSEcCtD
Clorazepate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0043	0.0134	CcSEcCtD
Clorazepate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00429	0.0134	CcSEcCtD
Clorazepate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00427	0.0133	CcSEcCtD
Clorazepate—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00416	0.013	CcSEcCtD
Clorazepate—Tension—Formoterol—chronic obstructive pulmonary disease	0.00416	0.013	CcSEcCtD
Clorazepate—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00412	0.0129	CcSEcCtD
Clorazepate—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00412	0.0129	CcSEcCtD
Clorazepate—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00411	0.0129	CcSEcCtD
Clorazepate—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00408	0.0329	CbGpPWpGaD
Clorazepate—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00397	0.0124	CcSEcCtD
Clorazepate—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00397	0.0124	CcSEcCtD
Clorazepate—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00393	0.0123	CcSEcCtD
Clorazepate—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00389	0.0122	CcSEcCtD
Clorazepate—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00389	0.0122	CcSEcCtD
Clorazepate—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00388	0.0121	CcSEcCtD
Clorazepate—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00375	0.0117	CcSEcCtD
Clorazepate—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00353	0.011	CcSEcCtD
Clorazepate—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00353	0.011	CcSEcCtD
Clorazepate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00333	0.0104	CcSEcCtD
Clorazepate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00313	0.00978	CcSEcCtD
Clorazepate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00313	0.00978	CcSEcCtD
Clorazepate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00308	0.00961	CcSEcCtD
Clorazepate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00308	0.00961	CcSEcCtD
Clorazepate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00306	0.00958	CcSEcCtD
Clorazepate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00301	0.00942	CcSEcCtD
Clorazepate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00301	0.0094	CcSEcCtD
Clorazepate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00298	0.00932	CcSEcCtD
Clorazepate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00298	0.00932	CcSEcCtD
Clorazepate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00295	0.00924	CcSEcCtD
Clorazepate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00292	0.00913	CcSEcCtD
Clorazepate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.0029	0.00908	CcSEcCtD
Clorazepate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00287	0.00896	CcSEcCtD
Clorazepate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00286	0.00895	CcSEcCtD
Clorazepate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00285	0.00891	CcSEcCtD
Clorazepate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00285	0.00891	CcSEcCtD
Clorazepate—GABRB2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00285	0.023	CbGpPWpGaD
Clorazepate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00285	0.0089	CcSEcCtD
Clorazepate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00283	0.00886	CcSEcCtD
Clorazepate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00282	0.0088	CcSEcCtD
Clorazepate—GABRA5—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00277	0.0223	CbGpPWpGaD
Clorazepate—GABRA3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00272	0.0219	CbGpPWpGaD
Clorazepate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.0027	0.00845	CcSEcCtD
Clorazepate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.0027	0.00844	CcSEcCtD
Clorazepate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00269	0.00841	CcSEcCtD
Clorazepate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00269	0.00839	CcSEcCtD
Clorazepate—GABRA2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00267	0.0215	CbGpPWpGaD
Clorazepate—GABRB3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00265	0.0214	CbGpPWpGaD
Clorazepate—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00264	0.00826	CcSEcCtD
Clorazepate—GABRG2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00261	0.021	CbGpPWpGaD
Clorazepate—GABRB2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00254	0.0205	CbGpPWpGaD
Clorazepate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00248	0.00776	CcSEcCtD
Clorazepate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00248	0.00776	CcSEcCtD
Clorazepate—GABRA5—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00247	0.0199	CbGpPWpGaD
Clorazepate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00243	0.0076	CcSEcCtD
Clorazepate—GABRA3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00242	0.0195	CbGpPWpGaD
Clorazepate—GABRA2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00238	0.0192	CbGpPWpGaD
Clorazepate—GABRB3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00237	0.0191	CbGpPWpGaD
Clorazepate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00234	0.00733	CcSEcCtD
Clorazepate—GABRG2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00232	0.0187	CbGpPWpGaD
Clorazepate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00229	0.00715	CcSEcCtD
Clorazepate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00229	0.00715	CcSEcCtD
Clorazepate—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00228	0.0184	CbGpPWpGaD
Clorazepate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00224	0.007	CcSEcCtD
Clorazepate—Rash—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00682	CcSEcCtD
Clorazepate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00682	CcSEcCtD
Clorazepate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00681	CcSEcCtD
Clorazepate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00681	CcSEcCtD
Clorazepate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00217	0.00677	CcSEcCtD
Clorazepate—Headache—Formoterol—chronic obstructive pulmonary disease	0.00217	0.00677	CcSEcCtD
Clorazepate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00216	0.00676	CcSEcCtD
Clorazepate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.00675	CcSEcCtD
Clorazepate—Rash—Montelukast—chronic obstructive pulmonary disease	0.00214	0.00668	CcSEcCtD
Clorazepate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00213	0.00667	CcSEcCtD
Clorazepate—Headache—Montelukast—chronic obstructive pulmonary disease	0.00212	0.00664	CcSEcCtD
Clorazepate—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00207	0.0167	CbGpPWpGaD
Clorazepate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00644	CcSEcCtD
Clorazepate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00643	CcSEcCtD
Clorazepate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.0064	CcSEcCtD
Clorazepate—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00203	0.0164	CbGpPWpGaD
Clorazepate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00169	0.0053	CcSEcCtD
Clorazepate—Bromazepam—CYP1A2—chronic obstructive pulmonary disease	0.00162	0.24	CrCbGaD
Clorazepate—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00159	0.0128	CbGpPWpGaD
Clorazepate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00157	0.00491	CcSEcCtD
Clorazepate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00154	0.00483	CcSEcCtD
Clorazepate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00139	0.0112	CbGpPWpGaD
Clorazepate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00135	0.0109	CbGpPWpGaD
Clorazepate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00133	0.0107	CbGpPWpGaD
Clorazepate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00131	0.0105	CbGpPWpGaD
Clorazepate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.0013	0.0105	CbGpPWpGaD
Clorazepate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00127	0.0103	CbGpPWpGaD
Clorazepate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00124	0.00387	CcSEcCtD
Clorazepate—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00123	0.00993	CbGpPWpGaD
Clorazepate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00385	CcSEcCtD
Clorazepate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00369	CcSEcCtD
Clorazepate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00369	CcSEcCtD
Clorazepate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00367	CcSEcCtD
Clorazepate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00367	CcSEcCtD
Clorazepate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00114	0.00916	CbGpPWpGaD
Clorazepate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00351	CcSEcCtD
Clorazepate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00111	0.00898	CbGpPWpGaD
Clorazepate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.0011	0.0089	CbGpPWpGaD
Clorazepate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00108	0.00874	CbGpPWpGaD
Clorazepate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00107	0.00863	CbGpPWpGaD
Clorazepate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00107	0.00859	CbGpPWpGaD
Clorazepate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00106	0.00853	CbGpPWpGaD
Clorazepate—GABRB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00105	0.00845	CbGpPWpGaD
Clorazepate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00104	0.00838	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00102	0.00821	CbGpPWpGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.001	0.00806	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000992	0.008	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000982	0.00792	CbGpPWpGaD
Clorazepate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000977	0.00305	CcSEcCtD
Clorazepate—GABRB3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000976	0.00787	CbGpPWpGaD
Clorazepate—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000974	0.00785	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000964	0.00777	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000958	0.00773	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000946	0.00763	CbGpPWpGaD
Clorazepate—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000933	0.00752	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00093	0.0075	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000924	0.00745	CbGpPWpGaD
Clorazepate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000908	0.00732	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000907	0.00731	CbGpPWpGaD
Clorazepate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.0009	0.00281	CcSEcCtD
Clorazepate—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000895	0.00721	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000884	0.00713	CbGpPWpGaD
Clorazepate—Clonazepam—ALB—chronic obstructive pulmonary disease	0.000876	0.13	CrCbGaD
Clorazepate—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000861	0.00694	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000859	0.00692	CbGpPWpGaD
Clorazepate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000858	0.00268	CcSEcCtD
Clorazepate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000858	0.00268	CcSEcCtD
Clorazepate—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000854	0.00689	CbGpPWpGaD
Clorazepate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000853	0.00267	CcSEcCtD
Clorazepate—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000843	0.0068	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000838	0.00675	CbGpPWpGaD
Clorazepate—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00083	0.00669	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000829	0.00668	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000823	0.00664	CbGpPWpGaD
Clorazepate—Flurbiprofen—ALB—chronic obstructive pulmonary disease	0.000822	0.122	CrCbGaD
Clorazepate—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000815	0.00657	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000809	0.00652	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000803	0.00647	CbGpPWpGaD
Clorazepate—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000801	0.00646	CbGpPWpGaD
Clorazepate—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000796	0.00641	CbGpPWpGaD
Clorazepate—Clozapine—CYP1A1—chronic obstructive pulmonary disease	0.000795	0.118	CrCbGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000793	0.00639	CbGpPWpGaD
Clorazepate—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000781	0.0063	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00078	0.00629	CbGpPWpGaD
Clorazepate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000777	0.00627	CbGpPWpGaD
Clorazepate—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.000777	0.115	CrCbGaD
Clorazepate—Clozapine—CYP1A2—chronic obstructive pulmonary disease	0.000767	0.114	CrCbGaD
Clorazepate—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000766	0.00617	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000753	0.00607	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000748	0.00603	CbGpPWpGaD
Clorazepate—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000746	0.00602	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000734	0.00592	CbGpPWpGaD
Clorazepate—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000707	0.0057	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000707	0.0057	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000686	0.00553	CbGpPWpGaD
Clorazepate—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000683	0.00551	CbGpPWpGaD
Clorazepate—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000655	0.00528	CbGpPWpGaD
Clorazepate—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00065	0.00524	CbGpPWpGaD
Clorazepate—Clozapine—HTR2A—chronic obstructive pulmonary disease	0.000647	0.0959	CrCbGaD
Clorazepate—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000642	0.00517	CbGpPWpGaD
Clorazepate—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000636	0.00513	CbGpPWpGaD
Clorazepate—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000625	0.00504	CbGpPWpGaD
Clorazepate—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000624	0.00503	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000619	0.00499	CbGpPWpGaD
Clorazepate—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000614	0.00495	CbGpPWpGaD
Clorazepate—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00061	0.00491	CbGpPWpGaD
Clorazepate—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000599	0.00483	CbGpPWpGaD
Clorazepate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000585	0.00472	CbGpPWpGaD
Clorazepate—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000523	0.00422	CbGpPWpGaD
Clorazepate—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00046	0.00371	CbGpPWpGaD
Clorazepate—Diazepam—ALB—chronic obstructive pulmonary disease	0.000448	0.0664	CrCbGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000429	0.00346	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00038	0.00306	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00038	0.00306	CbGpPWpGaD
Clorazepate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000372	0.003	CbGpPWpGaD
Clorazepate—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000367	0.00296	CbGpPWpGaD
Clorazepate—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000334	0.00269	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000301	0.00243	CbGpPWpGaD
Clorazepate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00027	0.00218	CbGpPWpGaD
Clorazepate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000266	0.00215	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000235	0.00189	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000225	0.00181	CbGpPWpGaD
Clorazepate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000219	0.00176	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000195	0.00157	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000193	0.00155	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000191	0.00154	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00019	0.00153	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000189	0.00152	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000186	0.0015	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000182	0.00147	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000181	0.00146	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000178	0.00143	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000163	0.00132	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00016	0.00129	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.00127	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000156	0.00125	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000133	0.00108	CbGpPWpGaD
Clorazepate—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000132	0.00106	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000132	0.00106	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000123	0.000989	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000121	0.000975	CbGpPWpGaD
Clorazepate—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000117	0.000942	CbGpPWpGaD
Clorazepate—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.000937	CbGpPWpGaD
Clorazepate—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.000925	CbGpPWpGaD
Clorazepate—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000113	0.000915	CbGpPWpGaD
Clorazepate—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000111	0.000898	CbGpPWpGaD
Clorazepate—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00011	0.000883	CbGpPWpGaD
Clorazepate—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000109	0.000877	CbGpPWpGaD
Clorazepate—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000107	0.000861	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	9.36e-05	0.000754	CbGpPWpGaD
Clorazepate—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.34e-05	0.000753	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.2e-05	0.0005	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.03e-05	0.000486	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.6e-05	0.000452	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.29e-05	0.000265	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.26e-05	0.000262	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.97e-05	0.000239	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.74e-05	0.000221	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.28e-05	0.000184	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.25e-05	0.000181	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.1e-05	0.000169	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.99e-05	0.00016	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.35e-05	0.000109	CbGpPWpGaD
Clorazepate—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.29e-05	0.000104	CbGpPWpGaD
